Ellume to make more over-the-counter COVID-19 tests for and in U.S.
The Department of Defense today awarded Ellume USA $231.8 million to ramp up domestic production of its COVID-19 diagnostic test, the first test users can perform fully at home without a prescription. The agency expects the contract to increase daily domestic production of the test by 640,000 by December.
The contract also will procure 8.5 million of the tests for U.S. distribution. The Food and Drug Administration recently authorized emergency use of the test, which can detect the SARS-CoV-2 virus in a nasal swab sample and report the results via a smartphone app.
Related News Articles
Headline
Centers for Medicare & Medicaid Services Administrator Mehmet Oz, M.D., and CMS Deputy Administrator and Director of Medicaid and CHIP Dan Brillman sat…
Headline
Flu and COVID-19 vaccination rates among all health care workers for the 2024-25 respiratory virus season was 76.3% and 40.2%, respectively, according to a…
Headline
A study published March 18 by Science Advances estimated that more than 155,000 U.S. COVID-19 deaths were uncounted during the COVID-19 pandemic. Researchers…
Headline
The Centers for Disease Control and Prevention Feb. 19 released a report on the low use of COVID-19 antiviral drugs among individuals age 65 and older, a…
Headline
The Centers for Medicare & Medicaid Services Jan. 26 released an advanced notice of proposed rulemaking seeking comments on potential future policies to…
Headline
The Food and Drug Administration today released two guidance documents; one related to low-risk wellness products (including certain wearable devices) and the…